The CUR-HSA-MPs exhibited efficacy in inhibiting the cell viability of Huh-7 and MCF-7 cells at a lower-dose treatment; these effects were higher than those in non-cancer cells (HDFB and MMN cells). Here, ALB is linked to cancer.